Cambridge gene therapy firm Dimension Therapeutics to be acquired By: Boston Business Journal via Business Journals August 25, 2017 at 08:25 AM EDT The proposed acquisition by Maryland-based Regenxbio values the company at just $86 million, a fraction of Dimension's value a year ago. Read More >> Related Stocks: Advantage Oil & Gas Ltd